Alpha Europe Federation

Marketing Authorisation Application for Zemaira


The news that CSL Behring has submitted an application to the European Medicines Agency for Marketing Authorisation for their Zemaira Augmentation (Replacement) Therapy product is very significant.  Zemaira is already approved in the United States and if the application is successful the product will be available in the Members States of the European Union.